110999 ⎘
ssRNA viruses negative-sense; Details; Paramyxoviridae; Respirovirus, e.g. Bovine, human parainfluenza 1,3 New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
PRE-FUSION HUMAN PIV1 F PROTEINS
#2STABILIZED TRIMERIC CLASS I FUSION PROTEINS
#3IMMUNOGENIC COMPOSITIONS AND USES THEREOF
#4METHODS OF INHIBITING PARAMYXOVIRIDAE FUSION TO A TARGET CELL
#5FUSOSOME COMPOSITIONS AND USES THEREOF
#6A SARS-COV-2 Human Parainfluenza Virus Type 3-Vectored Vaccine
#7RECOMBINANT HUMAN/BOVINE PARAINFLUENZA VIRUS 3 (B/HPIV3) EXPRESSING A CHIMERIC RSV/PIV3 F PROTEIN AND USES THEREOF
#8COMPOSITIONS AND METHODS FOR PREVENTING RSV AND PIV3 INFECTIONS
#9RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING SARS-COV-2 SPIKE PROTEIN AND ITS USE
#10Stabilized Pre-Fusion PIV3 F Proteins
#11Recombinant human parainfluenza virus type 1 expressing a chimeric RSV/HPIV1 f protein and uses thereof
#12Prefusion PIV F immunogens and their use
#13FUSOSOME COMPOSITIONS AND USES THEREOF
#14Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#15Recombinant human/bovine parainfluenza virus 1 (HPIV1) expressing a chimeric RSV/HPIV1 F protein and uses thereof
#16Virus causing respiratory tract illness in susceptible mammals
#17Virus causing respiratory tract illness in susceptible mammals
#18Recombinant human/bovine parainfluenza virus 3 (B/HPIV3) expressing a chimeric RSV/BPIV3 F protein and uses thereof
#19Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#20Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#21Virus causing respiratory tract illness in susceptible mammals
#22Virus causing respiratory tract illness in susceptible mammals
#23strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#24SEMI-LIVE RESPIRATORY SYNCYTIAL VIRUS VACCINE
#25Virus causing respiratory tract illness in susceptible mammals
#26Compositions and methods comprising hydrocarbon-stapled polypeptides
#27Method for production of reprogrammed cell using chromosomally unintegrated virus vector
#28Method for production of reprogrammed cell using chromosomally unintegrated virus vector
#29Virus causing respiratory tract illness in susceptible mammals
#30Alphavirus vectors for respiratory pathogen vaccines
#31Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#32Vaccine
#33RECOMBINANT PARAINFLUENZA VIRUS VACCINE COMPRISING HETEROLOGOUS ANTIGENS DERIVED FROM RESPIRATORY SYNCYTIAL VIRUS
#34Compositions and methods for the treatment of viral infections
#35Method for production of reprogrammed cell using chromosomally unintegrated virus vector
#36FUSION PROTEINS COMPRISING DP-178 AND OTHER VIRAL FUSION INHIBITOR PEPTIDES USEFUL FOR TREATING AIDS
#37Alphavirus Vectors for Respiratory Pathogen Vaccines
#38HUMAN PARAINFLUENZA VIRUS TYPE 3 EXPRESSING THE ENHANCED GREEN FLUORESCENT PROTEIN FOR USE IN HIGH-THROUGHPUT ANTIVIRAL ASSAYS
#39Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
#40METHODS AND COMPOSITIONS FOR INHIBITION OF MEMBRANE FUSION-ASSOCIATED EVENTS, INCLUDING HIV TRANSMISSION
#41NUCLEIC ACID SEQUENCES FOR THE AMPLIFICATION AND DETECTION OF RESPIRATORY VIRUSES
#42Cattle reproductive disease vaccines
#43Metapneumovirus strains and their use in vaccine formulations and sequences
#44Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus
#45Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#46Alphavirus Vectors for Respiratory Pathogen Vaccines
#47Chimeric immunogens
#48Chimeric immunogens
#49Compositions and Methods for Elimination of Unwanted Cells
#50Compositions and Methods for Elimination of Unwanted Cells
#51Compositions and Methods for Elimination of Unwanted Cells
#52Compositions and methods for elimination of unwanted cells
#53Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus
#54Chimeric immunogens
#55Chimeric immunogens
#56Chimeric immunogens
#57Cattle reproductive disease vaccines
#58Nucleic acids encoding DP-178 and other viral fusion inhibitor peptides useful for treating aids
#59Antifusogenic proteins comprising human immunodeficiency virus type 1 (HIV-1) gp41 DP-178 polypeptide variants and a macromolecular carrier
#60Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
#61Fusogenic, self-propagating blebs as immunogenic compositions
#62Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission
#63Method for the recovery of non-segmented, nagative-stranded RNA viruses from cDNA
#64Compositions and methods for elimination of unwanted cells
#65Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes
#66Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
#67Chimeric immunogens
#68Virus causing respiratory tract illness in susceptible mammals
#69Virus causing respiratory tract illness in susceptible mammals
#70Paramyxoviruses as gene transfer vectors to lung cells